Macrogen Consortium win tender for National Bio Big Data Project [Yahoo! Finance]
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: Yahoo! Finance
SEOUL, South Korea Dec. 23, 2024 /PRNewswire/ -- Macrogen a global healthcare company that specializes in precision medicine and Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today that they are honoured to support the National Bio Big Data project by sequencing and analysing 145,952 Korean genomes. (From left – right) Sooyeon Oh, CEO of CG Invites, Soonmyung Paik, CEO of Theragen Bio, Robert McBride, General Manager of Illumina Korea, Jeong-Sun Seo, Chairman of Macrogen Inc, Changhoon Kim, CEO of Macrogen Inc, and Cheol Ku Shim, CEO of DNAlink. The National Bio Big Data Project project has been running in Korea as a pilot project since 2020. During this period about 20,000 genomes were analysed, 10,000 of these including people with a rare disease The ultimate goal is to enable precision medicine by building a reference genome for about 770,000 Koreans by 2028 and a total of 1 million by 2032. "Being a part of this step
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Macrogen Consortium win tender for National Bio Big Data ProjectPR Newswire
- Ovation.io and Illumina Collaborate to Advance Genomic Data ResearchBusiness Wire
- Is There Now An Opportunity In Illumina, Inc. (NASDAQ:ILMN)? [Yahoo! Finance]Yahoo! Finance
- MicroStrategy, Palantir Added to Nasdaq 100, Moderna Removed [Yahoo! Finance Canada]Yahoo! Finance Canada
- Illumina, Inc. (NASDAQ: ILMN) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $165.00 price target on the stock, down previously from $190.00.MarketBeat
ILMN
Earnings
- 11/4/24 - Beat
ILMN
Sec Filings
- 1/2/25 - Form 4
- 12/9/24 - Form 4
- 12/6/24 - Form SC
- ILMN's page on the SEC website